AMGEN Inc (AMGN) concluded trading on Thursday at a closing price of $297.78, with 4.62 million shares of worth about $1.38 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.48% during that period and on February 06, 2025 the price saw a loss of about -3.26%. Currently the company’s common shares owned by public are about 537.00M shares, out of which, 536.25M shares are available for trading.
Stock saw a price change of 4.84% in past 5 days and over the past one month there was a price change of 15.16%. Year-to-date (YTD), AMGN shares are showing a performance of 14.25% which decreased to -7.51% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $253.30 but also hit the highest price of $346.85 during that period. The average intraday trading volume for AMGEN Inc shares is 3.85 million. The stock is currently trading 6.85% above its 20-day simple moving average (SMA20), while that difference is up 8.76% for SMA50 and it goes to -2.37% lower than SMA200.
AMGEN Inc (NASDAQ: AMGN) currently have 537.00M outstanding shares and institutions hold larger chunk of about 77.66% of that.
The stock has a current market capitalization of $160.07B and its 3Y-monthly beta is at 0.53. PE ratio of stock for trailing 12 months is 39.44, while it has posted earnings per share of $7.55 in the same period. Its PEG reads 9.62 and has Quick Ratio of 0.95 while making debt-to-equity ratio of 10.23. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AMGN, volatility over the week remained 3.31% while standing at 2.24% over the month.
Analysts are in expectations that AMGEN Inc (AMGN) stock would likely to be making an EPS of 4.3 in the current quarter, while forecast for next quarter EPS is 5.36 and it is 21.61 for next year. For the current quarter EPS, analysts have given the company a lowest target 3.89 which is 5.11 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 3.96 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 4.26% while it is estimated to increase by 4.58% in next year. EPS is likely to grow at an annualized rate of 4.10% for next 5-years, compared to annual growth of -10.10% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BofA Securities on December 10, 2024 offering an Underperform rating for the stock and assigned a target price of $256 to it. On November 14, 2024, Citigroup Initiated their recommendations, while on October 17, 2024, Bernstein Initiated their ratings for the stock with a price target of $380. Stock get a Hold rating from Truist on October 14, 2024.
